63 Microsatellite instability/mismatch repair biomarker testing disparities in patients with advanced colorectal cancer: Implications for immune checkpoint inhibitors
Main Author: | Bryan Iorgulescu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
by: Romain Cohen, et al.
Published: (2021-03-01) -
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
by: Qiao-Xuan Wang, et al.
Published: (2021-01-01) -
Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer
by: Jennifer Eriksson, et al.
Published: (2019-04-01) -
Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability
by: Madhura Deshpande, et al.
Published: (2020-11-01) -
The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability- high Metastatic Colorectal Cancer
by: Jong Yoon Lee
Published: (2021-05-01)